This will result in increased killing activity and infiltration of CD8 + T cells and NK cells, both in tumor and peripheral blood, partly through megakaryocyte-erythroid progenitors-secreted CCL5 and CXCL16 [27]. The gene discussed is CD8A; the disease is neoplasm.